Authors:
Press, OW
Eary, JF
Gooley, T
Gopal, AK
Liu, S
Rajendran, JG
Maloney, DG
Petersdorf, S
Bush, SA
Durack, LD
Martin, PJ
Fisher, DR
Wood, B
Borrow, JW
Porter, B
Smith, JP
Matthews, DC
Appelbaum, FR
Bernstein, ID
Citation: Ow. Press et al., A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, BLOOD, 96(9), 2000, pp. 2934-2942
Authors:
Mathioudakis, G
Storb, R
McSweeney, PA
Torok-Storb, B
Lansdorp, PM
Brummendorf, TH
Gass, MJ
Bryant, EM
Storek, J
Flowers, MED
Gooley, T
Nash, RA
Citation: G. Mathioudakis et al., Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients, BLOOD, 96(12), 2000, pp. 3991-3994
Authors:
Lin, MT
Tseng, LH
Frangoul, H
Gooley, T
Pei, J
Barsoukov, A
Akatsuka, Y
Hansen, JA
Citation: Mt. Lin et al., Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation, BLOOD, 95(12), 2000, pp. 3832-3839
Authors:
Georges, GE
Storb, R
Thompson, JD
Yu, C
Gooley, T
Bruno, B
Nash, RA
Citation: Ge. Georges et al., Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation, BLOOD, 95(10), 2000, pp. 3262-3269
Authors:
Shulman, HM
Wells, D
Gooley, T
Myerson, D
Bryant, E
Loken, MR
Citation: Hm. Shulman et al., The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry, AM J CLIN P, 112(4), 1999, pp. 513-523
Authors:
Boeckh, M
Gooley, T
Leisenring, W
Myerson, D
Corey, L
Citation: M. Boeckh et al., Does high-dose prophylactic acyclovir add benefit in allogeneic marrow transplant recipients receiving prophylactic or preemptive ganciclovir? Reply, J INFEC DIS, 180(2), 1999, pp. 572-574
Authors:
Tseng, LH
Lin, MT
Hansen, JA
Gooley, T
Pei, J
Smith, AG
Martin, EG
Petersdorf, EW
Martin, PJ
Citation: Lh. Tseng et al., Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation, BLOOD, 94(8), 1999, pp. 2911-2914
Authors:
Martin, PJ
Rowley, SD
Anasetti, C
Chauncey, TR
Gooley, T
Petersdorf, EW
van Burik, J
Flowers, MED
Storb, R
Appelbaum, FR
Hansen, JA
Citation: Pj. Martin et al., A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, BLOOD, 94(7), 1999, pp. 2192-2199
Authors:
Boeckh, M
Bowden, RA
Gooley, T
Myerson, D
Corey, L
Citation: M. Boeckh et al., Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients, BLOOD, 93(5), 1999, pp. 1781-1782